Acadian Asset Management
SCPH

Acadian Asset Management’s scPharmaceuticals SCPH Stock Holding History

Acadian Asset Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,060
Closed -$41K – 2097
2024
Q3 		$41K Buy
+9,060
New +$43.8K ﹤0.01% 1856
2020
Q4 		– Sell
-9,547
Closed -$72K – 2338
2020
Q3 		$72K Sell
9,547
-5,208
-35% -$40.7K ﹤0.01% 1756
2020
Q2 		$108K Buy
14,755
+4,408
+43% +$38.7K ﹤0.01% 1699
2020
Q1 		$76K Buy
10,347
+1,463
+16% +$10.6K ﹤0.01% 1411
2019
Q4 		$51K Hold
8,884
– – ﹤0.01% 1596
2019
Q3 		$53K Buy
8,884
+4,361
+96% +$24.6K ﹤0.01% 1604
2019
Q2 		$14K Buy
+4,523
New +$14.8K ﹤0.01% 1622
2019
Q1 		– Sell
-34,841
Closed -$131K – 2033
2018
Q4 		$131K Hold
34,841
– – ﹤0.01% 1210
2018
Q3 		$205K Buy
34,841
+5,026
+17% +$25.6K ﹤0.01% 1074
2018
Q2 		$169K Buy
+29,815
New +$306K ﹤0.01% 1130

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return